Physician
Pathology
Dr. Rebecca F. McClure, MD
|
|
Give Review
Rebecca McClure works in the field of Pathology. Dr. Rebecca F. McClure is a published MD as well. She has 50 publications published. The latest was: High-throughput sequencing using the ion torrent personal genome machine for clinical evaluation of somatic hypermutation status in chronic lymphocytic leukemia.
Publications
- High-throughput sequencing using the ion torrent personal genome machine for clinical evaluation of somatic hypermutation status in chronic lymphocytic Leukemia.
- Clonal mast cell Disease not meeting WHO criteria for diagnosis of mastocytosis: clinicopathologic features and comparison with indolent mastocytosis.
- Microgranular variant of Acute promyelocytic leukemia with normal conventional cytogenetics, negative PML/RARA FISH and positive PML/RARA transcripts by RT-PCR.
- PAX5-positive T-cell anaplastic large cell Lymphomas associated with extra copies of the PAX5 gene locus.
- Epstein-Barr virus-associated diffuse large B-cell Lymphoma arising on cardiac prostheses.
- WHO subvariants of indolent Mastocytosis: clinical details and prognostic evaluation in 159 consecutive adults.
- Prognostically relevant breakdown of 123 patients with systemic mastocytosis associated with other Myeloid malignancies.
- Chronic myeloid Leukemia with p190BCR-ABL: prevalence, morphology, tyrosine kinase inhibitor response, and kinase domain mutation analysis.
- Systemic Mastocytosis in 342 consecutive adults: survival studies and prognostic factors.
- Primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell Lymphoma: a clonal T-cell lymphoproliferative disorder with indolent behavior.
- Tumor suppressor p16 methylation in multiple Myeloma: biological and clinical implications.
- MPL515 mutations in myeloproliferative and other Myeloid disorders: a study of 1182 patients.
- Lenalidomide therapy in myelofibrosis with Myeloid metaplasia.
- Essential thrombocythemia beyond the first decade: life expectancy, long-term complication rates, and prognostic factors.
- The JAK2 V617F mutation is absent in patients with erythrocytosis due to high oxygen affinity hemoglobin variants.
- Adult B-cell Lymphomas with burkitt-like morphology are phenotypically and genotypically heterogeneous with aggressive clinical behavior.
- The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both "atypical" myeloproliferative disorders and Myelodysplastic syndromes.
- Histiocytes containing immunoglobulin crystals in the urine of a patient with IgA kappa plasmacytoma of the bladder.
- A new method to extract nuclei from paraffin-embedded tissue to study Lymphomas using interphase fluorescence in situ hybridization.
- Amiodarone-induced bone marrow granulomas: an unusual cause of reversible Pancytopenia.
- MPL W515 and JAK2 V617 mutation analysis in patients with refractory Anemia with ringed sideroblasts and an elevated platelet count.
- 20+ yr without leukemic or fibrotic transformation in essential thrombocythemia or polycythemia vera: predictors at diagnosis.
- Concurrent MPL515 and JAK2V617F mutations in myelofibrosis: chronology of clonal emergence and changes in mutant allele burden over time.
- Agnogenic Myeloid metaplasia with pleural extramedullary leukemic transformation.
- JAK2 mutation in essential thrombocythaemia: clinical associations and long-term prognostic relevance.
- Multiple Myeloma presenting initially as a solitary pleural effusion later complicated by malignant plasmacytic ascites.
- JAK2(V617F) and leukemic transformation in myelofibrosis with Myeloid metaplasia.
- Isolated isochromosome 17q: a distinct type of mixed myeloproliferative disorder/Myelodysplastic syndrome with an aggressive clinical course.
- JAK2 V617F is a rare finding in de novo Acute myeloid leukemia, but STAT3 activation is common and remains unexplained.
- Risk stratification for survival and leukemic transformation in essential thrombocythemia: a single institutional study of 605 patients.
- Janus kinase 2 (V617F) mutation status, signal transducer and activator of transcription-3 phosphorylation and impaired neutrophil apoptosis in myelofibrosis with myel...
- IDH1 and IDH2 mutation analysis in Chronic- and blast-phase myeloproliferative neoplasms.
- Discordant distribution of JAK2V617F mutation in siblings with familial Myeloproliferative disorders.
- A longitudinal study of the JAK2(V617F) mutation in myelofibrosis with Myeloid metaplasia: analysis at two time points.
- Serous borderline tumor of the paratestis: a report of seven cases.
- IDH1 and IDH2 mutation studies in 1473 patients with Chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis.
- A phase-2 trial of low-dose pomalidomide in myelofibrosis.
- Use of multiple displacement amplification to amplify genomic DNA before sequencing of the alpha and beta haemoglobin genes.
- Novel FISH probes designed to detect IGK-MYC and IGL-MYC rearrangements in B-Cell lineage malignancy identify a new breakpoint cluster region designated BVR2.
- Validation of two clinically useful assays for evaluation of JAK2 V617F mutation in Chronic myeloproliferative disorders.
- Recurrent IDH mutations in high-risk myelodysplastic syndrome or Acute myeloid leukemia with isolated del(5q).
- Clonal relationship between precursor B-cell Acute lymphoblastic leukemia and histiocytic sarcoma: a case report and discussion in the context of similar cases.
- Constitutive Fas ligand gene transcription in Sertoli Cells is regulated by Sp1.
- Elimination of senescent neutrophils by TNF-related apoptosis-inducing [corrected] ligand.
- Validation of immunoglobulin gene rearrangement detection by PCR using commercially available BIOMED-2 primers.
- Secondary erythrocytosis produced by the tyrosine kinase inhibitors sunitinib and sorafenib.
- The Alpha-1 Association Genetic Counseling Program: an innovative approach to service.
- Is PiSS Alpha-1 Antitrypsin Deficiency Associated with Disease?
- Instructive case report. A 26-year-old Indian woman with seizures and multiple intracranial mass lesions.
Conditions Treated
- Acute Leukemia
- Anemia
- Chronic Myeloid Leukemia (CML)
- Hodgkin's Disease
- View All
Doctors Specialties
- Hematology
- Hematopathology
- Pathology
Accepted Insurances
Education
-
Mayo School of Graduate Medical Education -
University of Toronto Faculty of Medicine
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1326269473 |
| Last Name Of The Provider | MCCLURE |
| First Name Of The Provider | REBECCA |
| View All |
Similar Doctors
|
|
Dr. Roxana S. Dronca, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kevin C. Halling, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Paula J. Santrach, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Herschel A. Carpenter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ryan E. Wilcox, MD |
|
|
Dr. Erin L. Schenk, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kebede Hussein, MD |
|
|
Dr. Justin D. Kreuter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Liping Liu, MD |
|
|
Dr. Brandon T. Larsen, MD |
|
|
Dr. Min Shi, MD
This Doctor is OpenDoctor Recommended.
|